COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
The 2012 London Regenerative Medicine EventAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Dr Shara Cohen. Continued improvement in the nation’s health depends upon the development of affordable and effective medicines and new therapeutic treatments. The last 20 years has seen the growth of a global healthcare industry based on human proteins produced in transformed mammalian cell lines, with a current market value of £30 billion/year. There is now an opportunity to replicate this growth in new industries using human stem cells in pharmaceutical and regenerative medicine applications. This meeting will focus on exploring the biological and engineering challenges lie ahead before cell based therapies can become an everyday reality. http://www.regonline.co.uk/regen2012 This talk is part of the Euroscicon series. This talk is included in these lists:Note that ex-directory lists are not shown. |
Other listsPEDAL - Research Centre for Play in Education, Development & Learning dh539 EMBL-EBI Science and Society ProgrammeOther talksDevelopmental cognitive neuroscience 5 selfish reasons to work reproducibly First order rigidity of higher rank arithmetic lattices (note the nonstandard day) A lifelong project in clay: Virtues of Unity 'Alas, poor Yorick!': Laurence Sterne's "A Sentimental Journey" after 250 years' Glucagon like peptide-1 receptor - a possible role for beta cell physiology in susceptibility to autoimmune diabetes The ‘Easy’ and ‘Hard’ Problems of Consciousness Art and Migration Protein Folding, Evolution and Interactions Symposium |